Is disrupted sleep a risk factor for Alzheimer’s disease? Evidence from a two-sample Mendelian randomization analysis
Author(s) -
Emma L. Anderson,
Rebecca C. Richmond,
Samuel E. Jones,
Gibran Hemani,
Kaitlin H. Wade,
Hassan S. Dashti,
Jacqueline M. Lane,
Heming Wang,
Richa Saxena,
Ben Brumpton,
Roxanna KorologouLinden,
Jonas B. Nielsen,
Bjørn Olav Åsvold,
Gonçalo R. Abecasis,
Elizabeth Coulthard,
Simon D. Kyle,
Robin N. Beaumont,
Jessica Tyrrell,
Timothy M. Frayling,
Marcus R. Munafò,
Andrew R. Wood,
Yoav BenShlomo,
Laura D. Howe,
Debbie A. Lawlor,
Michael N. Weedon,
George Davey Smith
Publication year - 2020
Publication title -
international journal of epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.406
H-Index - 208
eISSN - 1464-3685
pISSN - 0300-5771
DOI - 10.1093/ije/dyaa183
Subject(s) - mendelian randomization , alzheimer's disease , disease , risk factor , medicine , randomization , psychology , gerontology , randomized controlled trial , genetics , biology , gene , genotype , genetic variants
It is established that Alzheimer's disease (AD) patients experience sleep disruption. However, it remains unknown whether disruption in the quantity, quality or timing of sleep is a risk factor for the onset of AD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom